Abbott Laboratories
NYSE:ABT
Abbott Laboratories
Selling, General & Administrative
Abbott Laboratories
Selling, General & Administrative Peer Comparison
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbott Laboratories
NYSE:ABT
|
Selling, General & Administrative
$-10.9B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-5%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Selling, General & Administrative
$-4.7B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-7%
|
|
Boston Scientific Corp
NYSE:BSX
|
Selling, General & Administrative
$-5.2B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-7%
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Selling, General & Administrative
$-1.8B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-10%
|
|
Stryker Corp
NYSE:SYK
|
Selling, General & Administrative
$-6.8B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Selling, General & Administrative
$-2B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-13%
|
See Also
What is Abbott Laboratories's Selling, General & Administrative?
Selling, General & Administrative
-10.9B
USD
Based on the financial report for Dec 31, 2023, Abbott Laboratories's Selling, General & Administrative amounts to -10.9B USD.
What is Abbott Laboratories's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-5%
Over the last year, the Selling, General & Administrative growth was 2%. The average annual Selling, General & Administrative growth rates for Abbott Laboratories have been -4% over the past three years , -2% over the past five years , and -5% over the past ten years .